-
1
-
-
0036793302
-
Natural history of recurrent hepatitis C
-
Berenguer M. Natural history of recurrent hepatitis C. Liver Transpl 2002; 8(10 Suppl): S14-S18.
-
(2002)
Liver Transpl
, vol.8
, Issue.10 SUPPL.
-
-
Berenguer, M.1
-
2
-
-
0032924021
-
Recurrent and new hepatitis C virus infection after liver transplantation
-
Everhart JE, Wei Y, Eng H, et al. Recurrent and new hepatitis C virus infection after liver transplantation. Hepatology 1999; 29: 1220-1226.
-
(1999)
Hepatology
, vol.29
, pp. 1220-1226
-
-
Everhart, J.E.1
Wei, Y.2
Eng, H.3
-
3
-
-
0038798716
-
Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients
-
Mohsen AH, Easterbrook PJ, Taylor C, et al. Impact of human immunodeficiency virus (HIV) infection on the progression of liver fibrosis in hepatitis C virus infected patients. Gut 2003; 52:1035-1040.
-
(2003)
Gut
, vol.52
, pp. 1035-1040
-
-
Mohsen, A.H.1
Easterbrook, P.J.2
Taylor, C.3
-
4
-
-
0032899215
-
High incidence of allograft cirrhosis in hepatitis C virus genotype lb infection following transplantation: Relationship with rejection episodes
-
Prieto M, Berenguer M, Rayon JM, et al. High incidence of allograft cirrhosis in hepatitis C virus genotype lb infection following transplantation: relationship with rejection episodes. Hepatology 1999; 29: 250-256.
-
(1999)
Hepatology
, vol.29
, pp. 250-256
-
-
Prieto, M.1
Berenguer, M.2
Rayon, J.M.3
-
5
-
-
0032573676
-
Hepatitis C infection in patients undergoing liver retransplantation
-
Rosen HR, Martin P. Hepatitis C infection in patients undergoing liver retransplantation. Transplantation 1998; 66: 1612-1616.
-
(1998)
Transplantation
, vol.66
, pp. 1612-1616
-
-
Rosen, H.R.1
Martin, P.2
-
6
-
-
17344367309
-
Hepatitis C is a risk factor for death after liver retransplantation
-
Pelletier SJ, Schaubel DE, Punch JD, Wolfe RA, Port FK, Merion RM. Hepatitis C is a risk factor for death after liver retransplantation. Liver Transpl 2005; 11: 434-440.
-
(2005)
Liver Transpl
, vol.11
, pp. 434-440
-
-
Pelletier, S.J.1
Schaubel, D.E.2
Punch, J.D.3
Wolfe, R.A.4
Port, F.K.5
Merion, R.M.6
-
7
-
-
0035934568
-
Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C: A randomized trial
-
Manns MP, McHutchison JG, Gordon SC, et al. Peginterferon alpha-2b plus ribavirin compared with interferon alpha-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 2001; 358: 958-965.
-
(2001)
Lancet
, vol.358
, pp. 958-965
-
-
Manns, M.P.1
McHutchison, J.G.2
Gordon, S.C.3
-
8
-
-
0037179698
-
Peginterferon alpha-2a plus ribavirin for chronic hepatitis C virus infection
-
Fried MW, Shiffman ML, Reddy KR, et al. Peginterferon alpha-2a plus ribavirin for chronic hepatitis C virus infection. N Engl J Med 2002; 347: 975-982.
-
(2002)
N Engl J Med
, vol.347
, pp. 975-982
-
-
Fried, M.W.1
Shiffman, M.L.2
Reddy, K.R.3
-
9
-
-
2442683905
-
Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotype 2 or 3
-
Zeuzcm S, Hultcrantz R, Bourliere M, et al. Peginterferon alfa-2b plus ribavirin for treatment of chronic hepatitis C in previously untreated patients infected with HCV genotype 2 or 3. J Hepatol 2004; 40: 993-999.
-
(2004)
J Hepatol
, vol.40
, pp. 993-999
-
-
Zeuzcm, S.1
Hultcrantz, R.2
Bourliere, M.3
-
10
-
-
15644380122
-
Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferonalpha therapy
-
Marcellin P, Boyer N, Gervais A, et al. Long-term histologic improvement and loss of detectable intrahepatic HCV RNA in patients with chronic hepatitis C and sustained response to interferonalpha therapy. Ann Intern Med 1997; 127: 875-881.
-
(1997)
Ann Intern Med
, vol.127
, pp. 875-881
-
-
Marcellin, P.1
Boyer, N.2
Gervais, A.3
-
11
-
-
0031704927
-
10-year follow-up after interferon-alpha therapy for chronic hepatitis C
-
Lau DT, Kleiner DE, Ghany MG, Park Y, Schmid P, Hoofnagle JH. 10-year follow-up after interferon-alpha therapy for chronic hepatitis C. Hepatology 1998; 28: 1121-1127.
-
(1998)
Hepatology
, vol.28
, pp. 1121-1127
-
-
Lau, D.T.1
Kleiner, D.E.2
Ghany, M.G.3
Park, Y.4
Schmid, P.5
Hoofnagle, J.H.6
-
12
-
-
14544270030
-
Liver Transplantation and hepatitis C virus: Systematic review of antiviral therapy
-
Triantos C, Samonakis D, Stigliano R, Thalheimer U, Patch D, Burroughs A. Liver Transplantation and hepatitis C virus: systematic review of antiviral therapy. Transplantation 2005; 79: 261-268.
-
(2005)
Transplantation
, vol.79
, pp. 261-268
-
-
Triantos, C.1
Samonakis, D.2
Stigliano, R.3
Thalheimer, U.4
Patch, D.5
Burroughs, A.6
-
13
-
-
33746924102
-
Treating hepatitis C infection in liver transplant recipients
-
Terrault N, Berenguer M. Treating hepatitis C infection in liver transplant recipients. Liver Transpl 2006; 12: 1192-1204.
-
(2006)
Liver Transpl
, vol.12
, pp. 1192-1204
-
-
Terrault, N.1
Berenguer, M.2
-
14
-
-
2342418781
-
Effectiveness of interferon alpha-2b and ribavirin combination therapy in the treatment of naive chronic hepatitis C patients in clinical practice
-
Shehab TM, Fontana RJ, Oberhelman K, Marrero JA, Su GL, Lok AS. Effectiveness of interferon alpha-2b and ribavirin combination therapy in the treatment of naive chronic hepatitis C patients in clinical practice. Clin Gastroenterol Hepatol 2004; 2: 425-431.
-
(2004)
Clin Gastroenterol Hepatol
, vol.2
, pp. 425-431
-
-
Shehab, T.M.1
Fontana, R.J.2
Oberhelman, K.3
Marrero, J.A.4
Su, G.L.5
Lok, A.S.6
-
15
-
-
0036207348
-
The association between hepatitis C infection and survival after orthotopic liver transplantation
-
Forman LM, Lewis JD, Berlin JA, Feldman HI, Lucey MR. The association between hepatitis C infection and survival after orthotopic liver transplantation. Gastroenterology 2002; 122: 889-896.
-
(2002)
Gastroenterology
, vol.122
, pp. 889-896
-
-
Forman, L.M.1
Lewis, J.D.2
Berlin, J.A.3
Feldman, H.I.4
Lucey, M.R.5
-
16
-
-
0033807694
-
Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation
-
Berenguer M, Prieto M, Rayon JM, et al. Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation. Hepatology 2000; 32: 852-858.
-
(2000)
Hepatology
, vol.32
, pp. 852-858
-
-
Berenguer, M.1
Prieto, M.2
Rayon, J.M.3
-
17
-
-
33745343818
-
Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: A review and quantitative analysis
-
Wang CS, Ko HH, Yoshida EM, Marra CA, Richardson K. Interferon-based combination anti-viral therapy for hepatitis C virus after liver transplantation: a review and quantitative analysis. Am J Transplant 2006; 6: 1586-1599.
-
(2006)
Am J Transplant
, vol.6
, pp. 1586-1599
-
-
Wang, C.S.1
Ko, H.H.2
Yoshida, E.M.3
Marra, C.A.4
Richardson, K.5
-
18
-
-
1642293907
-
Treatment of recurrent hepatitis C after liver transplantation: A pilot study of peginterferon alfa-2b and ribavirin combination
-
Dumortier J, Scoazec JY, Chevallier P, Boillot O. Treatment of recurrent hepatitis C after liver transplantation: a pilot study of peginterferon alfa-2b and ribavirin combination. J Hepatol 2004; 40: 669-674.
-
(2004)
J Hepatol
, vol.40
, pp. 669-674
-
-
Dumortier, J.1
Scoazec, J.Y.2
Chevallier, P.3
Boillot, O.4
-
19
-
-
20444377637
-
Combined treatment with pegylatcd interferon (alfa-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation
-
Castells L, Vargas V, Allende H, et al. Combined treatment with pegylatcd interferon (alfa-2b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation. J Hepatol 2005; 43: 53-59.
-
(2005)
J Hepatol
, vol.43
, pp. 53-59
-
-
Castells, L.1
Vargas, V.2
Allende, H.3
-
20
-
-
8644285360
-
Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy
-
Neff GW, Montalbano M, O'Brien CB, et al. Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy. Transplantation 2004; 78: 1303-1307.
-
(2004)
Transplantation
, vol.78
, pp. 1303-1307
-
-
Neff, G.W.1
Montalbano, M.2
O'Brien, C.B.3
-
21
-
-
33747519995
-
Treatment of patients with recurrent hepatitis C after liver transplantation with peginterferon alfa-2B plus ribavirin
-
Neumann U, Puhl G, Bahra M, et al. Treatment of patients with recurrent hepatitis C after liver transplantation with peginterferon alfa-2B plus ribavirin. Transplantation 2006; 82: 43-47.
-
(2006)
Transplantation
, vol.82
, pp. 43-47
-
-
Neumann, U.1
Puhl, G.2
Bahra, M.3
-
22
-
-
22444439336
-
Pegylated-interferon alpha 2b and ribavirin for recurrent hepatitis C after liver transplantation: From a Canadian experience to recommendations for therapy
-
Babatin M, Schindel L, Burak KW. Pegylated-interferon alpha 2b and ribavirin for recurrent hepatitis C after liver transplantation: From a Canadian experience to recommendations for therapy. Can J Gastroenterol 2005; 19: 359-365.
-
(2005)
Can J Gastroenterol
, vol.19
, pp. 359-365
-
-
Babatin, M.1
Schindel, L.2
Burak, K.W.3
-
23
-
-
33745997054
-
Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C
-
Berenguer M, Palau A, Fernandez A, et al. Efficacy, predictors of response, and potential risks associated with antiviral therapy in liver transplant recipients with recurrent hepatitis C. Liver Transpl 2006; 12: 1067-1076.
-
(2006)
Liver Transpl
, vol.12
, pp. 1067-1076
-
-
Berenguer, M.1
Palau, A.2
Fernandez, A.3
-
24
-
-
33748497126
-
Hepatitis C recurrence after liver transplantation: Viral and histologic response to full-dose PEG-interferon and ribavirin
-
Oton E, Barcena R, Moreno-Planas JM, et al. Hepatitis C recurrence after liver transplantation: viral and histologic response to full-dose PEG-interferon and ribavirin. Am J Transplant 2006; 6: 2348-2355.
-
(2006)
Am J Transplant
, vol.6
, pp. 2348-2355
-
-
Oton, E.1
Barcena, R.2
Moreno-Planas, J.M.3
-
25
-
-
0037302607
-
Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C recurrence
-
Bizollon T, Ahmed SN, Radenne S, et al. Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C recurrence. Gut 2003; 52: 283-287.
-
(2003)
Gut
, vol.52
, pp. 283-287
-
-
Bizollon, T.1
Ahmed, S.N.2
Radenne, S.3
-
26
-
-
1242307253
-
Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C
-
Abdclmalek MF, Firpi RJ, Soldevila-Pico C, et al. Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C. Liver Transpl 2004; 10: 199-207.
-
(2004)
Liver Transpl
, vol.10
, pp. 199-207
-
-
Abdclmalek, M.F.1
Firpi, R.J.2
Soldevila-Pico, C.3
-
27
-
-
34247863801
-
Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: A randomized controlled study
-
Carrion JA, Navasa M, Garcia-Retortillo M, et al. Efficacy of antiviral therapy on hepatitis C recurrence after liver transplantation: a randomized controlled study. Gastroenterology 2007; 132: 1746-1756.
-
(2007)
Gastroenterology
, vol.132
, pp. 1746-1756
-
-
Carrion, J.A.1
Navasa, M.2
Garcia-Retortillo, M.3
-
28
-
-
34250866552
-
Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence
-
Sharma P, Marrero JA, Fontana RJ, et al. Sustained virologic response to therapy of recurrent hepatitis C after liver transplantation is related to early virologic response and dose adherence. Liver Transpl 2007;13:1100-1108.
-
(2007)
Liver Transpl
, vol.13
, pp. 1100-1108
-
-
Sharma, P.1
Marrero, J.A.2
Fontana, R.J.3
-
29
-
-
22944435223
-
Successful treatment of hepatitis C reinfection with interferon-alpha2b and ribavirin after liver transplantation. A long-term follow-up
-
Yedibela S, Schuppan D, Muller V, et al. Successful treatment of hepatitis C reinfection with interferon-alpha2b and ribavirin after liver transplantation. A long-term follow-up. Liver Int 2005; 25: 717-722.
-
(2005)
Liver Int
, vol.25
, pp. 717-722
-
-
Yedibela, S.1
Schuppan, D.2
Muller, V.3
-
30
-
-
3442898180
-
Prevention and treatment of hepatitis C virus recurrence after liver transplantation
-
Garcia-Retortillo M, Forns X. Prevention and treatment of hepatitis C virus recurrence after liver transplantation. J Hcpatol 2004; 41: 2-10.
-
(2004)
J Hcpatol
, vol.41
, pp. 2-10
-
-
Garcia-Retortillo, M.1
Forns, X.2
-
31
-
-
1942450774
-
Impact of pcgylated interferon alfa-2b and ribavirin on liver fibrosis for recurrent hepatitis C in liver transplantation - a single center experience [Abstr.]
-
Mukherjec S, Gilroy RK, Rogge J, et al. Impact of pcgylated interferon alfa-2b and ribavirin on liver fibrosis for recurrent hepatitis C in liver transplantation - a single center experience [Abstr.]. Hepatology 2003; 38: 227A.
-
(2003)
Hepatology
, vol.38
-
-
Mukherjec, S.1
Gilroy, R.K.2
Rogge, J.3
-
32
-
-
10744233319
-
Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylatcd interferon alpha2b and ribavirin: An open-label scries
-
Rodriguez-Luna H, Khatib A, Sharma P, et al. Treatment of recurrent hepatitis C infection after liver transplantation with combination of pegylatcd interferon alpha2b and ribavirin: an open-label scries. Transplantation 2004; 77: 190-194.
-
(2004)
Transplantation
, vol.77
, pp. 190-194
-
-
Rodriguez-Luna, H.1
Khatib, A.2
Sharma, P.3
-
33
-
-
34250794991
-
Ribavirin with cither standard or pcgylated interferon to treat recurrent hepatitis C after liver transplantation
-
Cicinnati VR, Iacob S, Klein CG, ct al. Ribavirin with cither standard or pcgylated interferon to treat recurrent hepatitis C after liver transplantation. Aliment Pharmacol Ther. 2007; 26: 291-303.
-
(2007)
Aliment Pharmacol Ther
, vol.26
, pp. 291-303
-
-
Cicinnati, V.R.1
Iacob, S.2
Klein, C.G.3
ct al4
-
34
-
-
0242624204
-
Pegylatcd interferon alfa-2b plus ribavirin in patients with hepatitis C reinfection after OLT [Abstr.]
-
Bahra M, Neumann UP, Berg T, et al. Pegylatcd interferon alfa-2b plus ribavirin in patients with hepatitis C reinfection after OLT [Abstr.]. Am J Transplant 2003; 3: 432.
-
(2003)
Am J Transplant
, vol.3
, pp. 432
-
-
Bahra, M.1
Neumann, U.P.2
Berg, T.3
-
35
-
-
19944430229
-
Pegasys Transplant Study Group. Peginterferon alfa-2a for hepatitis C after liver transplantation: Two randomized, controlled trials
-
Chalasani N, Manzarbeitia C, Fcrenci P, et al. Pegasys Transplant Study Group. Peginterferon alfa-2a for hepatitis C after liver transplantation: two randomized, controlled trials. Hepatology 2005; 41:289-298.
-
(2005)
Hepatology
, vol.41
, pp. 289-298
-
-
Chalasani, N.1
Manzarbeitia, C.2
Fcrenci, P.3
-
36
-
-
0028316548
-
Hepatitis C virus infection is a risk factor for liver failure from vcno-occlusive disease after bone marrow transplantation
-
Frickhofcn N, Wiesncth M, Jainta C, et al. Hepatitis C virus infection is a risk factor for liver failure from vcno-occlusive disease after bone marrow transplantation. Blood 1994; 83: 1998-2004.
-
(1994)
Blood
, vol.83
, pp. 1998-2004
-
-
Frickhofcn, N.1
Wiesncth, M.2
Jainta, C.3
-
37
-
-
6444236097
-
One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection
-
Firpi R, Abdelmalek MF, Soldevila-Pico C, et al. One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infection. Liver Transpl 2004; 10: 1240-1247.
-
(2004)
Liver Transpl
, vol.10
, pp. 1240-1247
-
-
Firpi, R.1
Abdelmalek, M.F.2
Soldevila-Pico, C.3
|